James E. Galvin

19.4k total citations · 1 hit paper
170 papers, 6.1k citations indexed

About

James E. Galvin is a scholar working on Psychiatry and Mental health, Neurology and General Health Professions. According to data from OpenAlex, James E. Galvin has authored 170 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Psychiatry and Mental health, 32 papers in Neurology and 31 papers in General Health Professions. Recurrent topics in James E. Galvin's work include Dementia and Cognitive Impairment Research (71 papers), Parkinson's Disease Mechanisms and Treatments (30 papers) and Geriatric Care and Nursing Homes (18 papers). James E. Galvin is often cited by papers focused on Dementia and Cognitive Impairment Research (71 papers), Parkinson's Disease Mechanisms and Treatments (30 papers) and Geriatric Care and Nursing Homes (18 papers). James E. Galvin collaborates with scholars based in United States, Japan and United Kingdom. James E. Galvin's co-authors include John Q. Trojanowski, I.G. Brown, R.A. MacGill, Virginia M.‐Y. Lee, Virginia M.-Y. Lee, Kunihiro Uryu, David K. Johnson, Angela Taylor, John C. Morris and Steven H. Zarit and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Applied Physics Letters.

In The Last Decade

James E. Galvin

157 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

1998 558 citations James E. Galvin, John Q. Trojanowski et al. profile →

Peers

Countries citing papers authored by James E. Galvin

Since Specialization

Citations

This map shows the geographic impact of James E. Galvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Galvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Galvin more than expected).

Fields of papers citing papers by James E. Galvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Galvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Galvin. The network helps show where James E. Galvin may publish in the future.

Co-authorship network of co-authors of James E. Galvin

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Galvin. A scholar is included among the top collaborators of James E. Galvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Galvin. James E. Galvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies 2025 ·Alzheimer s & Dementia ·Jennifer G. Goldman, Bradley F. Boeve, Douglas Galasko, John‐Paul Taylor, James E. Galvin, James B. Leverenz, ‪Frederic Blanc‬, Glenda M. Halliday, (unknown), Afina W. Lemstra, Iracema Leroi, Simon J.G. Lewis, Irene Litvan, (unknown), John T. O’Brien, Sonja W. Scholz, Dag Aarsland, Manabu Ikeda, Ian G. McKeith, Angela E. Taylor	1
2	Sequential patterning of dynamic brain states distinguish Parkinson’s disease patients with mild cognitive impairments 2025 ·NeuroImage Clinical ·Aaron S. Kemp, (unknown), (unknown), James E. Galvin, Fred Prior, Linda Larson‐Prior	0
3	Cognivue Clarity ^® characterizes amyloid status and preclinical Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study 2025 ·Journal of Alzheimer s Disease ·James E. Galvin, (unknown), (unknown), (unknown), Ernest S. Fung	0
4	Prevalence of Multiple Chronic Conditions in Older Adults with Undiagnosed Mild Cognitive Impairment and Alzheimer’s Disease and Related Dementias in Primary Care 2025 ·Clinical Interventions in Aging ·(unknown), Arthur H. Owora, Zina Ben Miled, Paul Dexter, Ambar Kulshreshtha, (unknown), Bowen Jiang, (unknown), (unknown), James E. Galvin, Malaz Boustani, Nicole R. Fowler	0
5	Comparison of Wearable and Depth-Sensing Technologies with Electronic Walkway for Comprehensive Gait Analysis 2025 ·Sensors ·(unknown), (unknown), (unknown), Magdalena I. Tolea, James E. Galvin, Behnaz Ghoraani	1
6	Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers 2024 ·JAMA Network Open ·Ambar Kulshreshtha, (unknown), Nicole R. Fowler, (unknown), Zina Ben Miled, Arthur H. Owora, James E. Galvin, Malaz Boustani	9
7	Caregiver Experiences and Burden in Moderate-Advanced Dementia With Lewy Bodies 2024 ·Neurology Clinical Practice ·Melissa J. Armstrong, Yunfeng Dai, (unknown), (unknown), Henry L. Paulson, (unknown), Julie A. Fields, Angela Lunde, Leah K. Forsberg, Bradley F. Boeve, Carol A. Manning, James E. Galvin, Angela Taylor, Zhigang Li	2
8	APOE ε4 carrier status moderates the effect of lifestyle factors on cognitive reserve 2024 ·Alzheimer s & Dementia ·Deirdre O’Shea, (unknown), (unknown), (unknown), Lilah M. Besser, James E. Galvin	6
9	Neuropsychiatric symptoms in people living with dementia receiving home health services 2023 ·Journal of the American Geriatrics Society ·(unknown), Shih‐Yin Lin, (unknown), Jason Fletcher, Tracy Chippendale, (unknown), (unknown), James E. Galvin, Randall Rupper, Abraham A. Brody	1
10	Best Practices for Communicating a Diagnosis of Dementia 2023 ·Neurology Clinical Practice ·Melissa J. Armstrong, (unknown), Mónica Rosselli, Rosie E. Curiel, (unknown), James E. Galvin, Christian Lachner, Amanda Smith, (unknown), (unknown), (unknown), (unknown), (unknown), Carma L. Bylund	6
11	Caregiver preparedness is associated with desire to seek long‐term care admission of hospitalized persons with dementia 2023 ·International Journal of Geriatric Psychiatry ·(unknown), Rhonda BeLue, Barbara Resnick, (unknown), Diane Berish, James E. Galvin, Marie Boltz	1
12	The age-specific comorbidity burden of mild cognitive impairment: a US claims database study 2023 ·Alzheimer s Research & Therapy ·Gang Li, Nicola Toschi, Viswanath Devanarayan, Richard Batrla, (unknown), Min Cho, (unknown), Feride Frech, James E. Galvin, David Henley, Soeren Mattke, Susan De Santi, Harald Hampel	11
13	Overcoming the COVID-19 Pandemic for Dementia Research: Engaging Rural, Older, Racially and Ethnically Diverse Church Attendees in Remote Recruitment, Intervention and Assessment 2021 ·SHILAP Revista de lepidopterología ·Lisa Kirk Wiese, Ishan C. Williams, Nancy E. Schoenberg, James E. Galvin, (unknown)	7
14	Protocol for an observational cohort study identifying factors predicting accurately end of life in dementia with Lewy bodies and promoting quality end-of-life experiences: the PACE-DLB study 2021 ·BMJ Open ·Melissa J. Armstrong, Henry L. Paulson, (unknown), Julie A. Fields, Angela Lunde, Bradley F. Boeve, Carol A. Manning, James E. Galvin, Angela Taylor, Zhigang Li	5
15	Detecting dementia among older, ethnically diverse residents of rural subsidized housing 2020 ·Geriatric Nursing ·Lisa Kirk Wiese, Christine L. Williams, Debra Hain, David Newman, (unknown), (unknown), James E. Galvin	13
16	Factors Associated With Physical Performance Measures in a Multiethnic Cohort of Older Adults 2018 ·Gerontology and Geriatric Medicine ·Antoneta Granic, Helen Mossop, Gabriella Engström, Karen Davies, Richard Dodds, James E. Galvin, Joseph G. Ouslander, Ruth M. Tappen, Avan Aihie Sayer	4
17	A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease 2011 ·Neurology ·Mary Sano, Karen L. Bell, Douglas Galasko, James E. Galvin, Ronald G. Thomas, C H van Dyck, Paul Aisen	244
18	Dementia With Lewy Bodies 2003 ·Archives of Neurology ·James E. Galvin	9
19	RNA sequestration to pathological lesions of neurodegenerative diseases 1998 ·Acta Neuropathologica ·Stephen D. Ginsberg, James E. Galvin, (unknown), Virginia M.‐Y. Lee, Eliezer Masliah, John Q. Trojanowski	106
20	Measurements of vacuum arc ion charge state distributions 1988 ·eScholarship (California Digital Library) ·I.G. Brown, James E. Galvin	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact